Rfg Advisory, LLC Abbott Laboratories Transaction History

Rfg Advisory, LLC

$3.18 Billion
Q3 2024

A detailed history of Rfg Advisory, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rfg Advisory, LLC holds 11,713 shares of ABT stock, worth $1.34 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,713

Previous 13,637 14.11%

Holding current value

$1.34 Million

Previous $1.42 Million 5.79%

% of portfolio

0.04%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$100.07 - $118.13 $192,534 - $227,282	-1,924 Reduced 14.11%	11,713 $1.34 Million
Q2 2024 Jul 15, 2024	BUY	$100.73 - $112.44 $39,385 - $43,964	391 Added 2.95%	13,637 $1.42 Million
Q1 2024 Apr 11, 2024	BUY	$109.52 - $120.96 $85,644 - $94,590	782 Added 6.27%	13,246 $1.51 Million
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $76,841 - $94,060	-852 Reduced 6.4%	12,464 $1.37 Million
Q3 2023 Oct 16, 2023	BUY	$95.53 - $114.62 $41,651 - $49,974	436 Added 3.39%	13,316 $1.29 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $33,257 - $37,055	-330 Reduced 2.5%	12,880 $1.4 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $52,013 - $61,223	537 Added 4.24%	13,210 $1.34 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $179,663 - $210,772	-1,890 Reduced 12.98%	12,673 $1.39 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $94,921 - $109,901	981 Added 7.22%	14,563 $1.45 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $121,871 - $147,303	1,194 Added 9.64%	13,582 $1.48 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $15,962 - $19,465	-140 Reduced 1.12%	12,388 $1.47 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $113,681 - $139,196	984 Added 8.52%	12,528 $1.76 Million
Q3 2021 Oct 19, 2021	BUY	$116.66 - $129.06 $203,105 - $224,693	1,741 Added 17.76%	11,544 $1.36 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $118,802 - $139,847	1,123 Added 12.94%	9,803 $1.14 Million
Q1 2021 Apr 19, 2021	BUY	$108.84 - $128.23 $24,706 - $29,108	227 Added 2.69%	8,680 $1.04 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $41,265 - $44,967	-393 Reduced 4.44%	8,453 $943,000
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $8,339 - $10,127	91 Added 1.04%	8,846 $963,000
Q2 2020 Aug 03, 2020	BUY	$76.57 - $98.0 $17,611 - $22,540	230 Added 2.7%	8,755 $800,000
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $60,809 - $88,920	968 Added 12.81%	8,525 $673,000
Q4 2019 Jan 22, 2020	BUY	$78.51 - $87.4 $211,270 - $235,193	2,691 Added 55.3%	7,557 $656,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $10,557 - $11,447	129 Added 2.72%	4,866 $407,000
Q2 2019 Aug 23, 2019	BUY	$72.88 - $85.0 $345,232 - $402,645	4,737 New	4,737 $397,000
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $270,822 - $315,860	-3,716 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$66.22 - $80.06 $246,073 - $297,502	3,716 New	3,716 $298,000
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $292,069 - $330,872	-4,455 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $270,908 - $326,818	4,455 New	4,455 $327,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.

Account